These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7512087)

  • 21. Overview of the biologic markers of breast cancer.
    Porter-Jordan K; Lippman ME
    Hematol Oncol Clin North Am; 1994 Feb; 8(1):73-100. PubMed ID: 8150784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.
    Negrini M; Sabbioni S; Haldar S; Possati L; Castagnoli A; Corallini A; Barbanti-Brodano G; Croce CM
    Cancer Res; 1994 Apr; 54(7):1818-24. PubMed ID: 8137297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour angiogenesis and C-myc expression in breast carcinomas.
    Shanmugham R; Gopalan R; Shanthi P; Krishnan KB
    Indian J Pathol Microbiol; 2004 Jul; 47(3):340-2. PubMed ID: 16295419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
    Jin Q; Hemminki K; Enquist K; Lenner P; Grzybowska E; Klaes R; Henriksson R; Chen B; Pamula J; Pekala W; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Hallmans G; Försti A
    Clin Cancer Res; 2005 May; 11(10):3647-53. PubMed ID: 15897560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.
    Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of P53 gene mutations in a large series of node-negative breast cancer patients.
    Falette N; Paperin MP; Treilleux I; Gratadour AC; Peloux N; Mignotte H; Tooke N; Löfman E; Inganäs M; Bremond A; Ozturk M; Puisieux A
    Cancer Res; 1998 Apr; 58(7):1451-5. PubMed ID: 9537247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Proliferative activity and defective replication in breast cancer].
    Kreipe H; Zeidler R; Kneitz H; Feist H
    Verh Dtsch Ges Pathol; 1994; 78():36-7. PubMed ID: 7534009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapy.
    Chevillard S; Lebeau J; Pouillart P; de Toma C; Beldjord C; Asselain B; Klijanienko J; Fourquet A; Magdelénat H; Vielh P
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2471-8. PubMed ID: 9815649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 alleles.
    Runnebaum IB; Yee JK; Kieback DG; Sukumar S; Friedmann T
    Anticancer Res; 1994; 14(3A):1137-44. PubMed ID: 8074464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of sequential genetic alterations relevant for breast cancer development.
    Niederacher D; Schnürch HG; An HX; Ellenberger I; Dall P; van Roeyen CR; Küppers V; Beckmann MW
    Eur J Cancer Prev; 1996 Dec; 5(6):497-503. PubMed ID: 9061283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The p53 tumor suppressor gene in breast cancer.
    Elledge RM; Allred DC
    Breast Cancer Res Treat; 1994; 32(1):39-47. PubMed ID: 7819584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenesis and breast cancer.
    Folkman J
    J Clin Oncol; 1994 Mar; 12(3):441-3. PubMed ID: 7509850
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prognosis in cancer of the breast in relation to the topography of the tumor].
    Rozenbakh VP
    Klin Lech Zlokach Novoobraz; 1968; 11():65-9. PubMed ID: 5725414
    [No Abstract]   [Full Text] [Related]  

  • 34. [Stromal reaction of the breast cancer tissue and its relation to prognosis].
    Fujimori M; Izuo M; Kawai T; Takano A
    Gan No Rinsho; 1967 Oct; 13(10):855-60. PubMed ID: 5627465
    [No Abstract]   [Full Text] [Related]  

  • 35. The p53 tumor-suppressor gene in human breast cancer.
    Allred DC; Elledge R; Clark GM; Fuqua SA
    Cancer Treat Res; 1994; 71():63-77. PubMed ID: 7946959
    [No Abstract]   [Full Text] [Related]  

  • 36. A clinical method for estimating the rate of growth of a cancer.
    Feinstein AR
    Yale J Biol Med; 1969 Jun; 41(6):422-33. PubMed ID: 5803087
    [No Abstract]   [Full Text] [Related]  

  • 37. Breast cancer angio-histogenesis: through a narrow window.
    Page DL; Dupont WD
    J Natl Cancer Inst; 1992 Dec; 84(24):1850-1. PubMed ID: 1281235
    [No Abstract]   [Full Text] [Related]  

  • 38. Breast cancer: cellular and molecular biology.
    Cancer Treat Res; 1988; 40():1-389. PubMed ID: 2908647
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular biology of breast cancer.
    Ingvarsson S
    Oncol Rep; 2000; 7(5):1163-70. PubMed ID: 11182905
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic factors in breast cancer: biology or chronology?
    Lancet; 1992 Aug; 340(8818):517-8. PubMed ID: 1354281
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.